dazmegrel has been researched along with Autoimmune Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnett, AH; Bennett, J; Britton, JR; Dallinger, K; Leatherdale, BA; Polak, A; Rowe, D; Toop, M; Wakelin, K | 1 |
Barnett, AH; Dallinger, KJ; Gyde, OH; Toop, M | 1 |
Armstrong, S; Barnett, AH; Chisholm, I; Leatherdale, BA; Thorogood, P; Wakelin, K | 1 |
3 trial(s) available for dazmegrel and Autoimmune Diabetes
Article | Year |
---|---|
Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes.
Topics: Adult; Albuminuria; Clinical Trials as Topic; Creatinine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Oxidoreductases; Thromboxane B2; Thromboxane-A Synthase | 1984 |
Specific thromboxane synthetase inhibition and haemostasis in insulin-dependent diabetics.
Topics: beta-Thromboglobulin; Diabetes Mellitus, Type 1; Fibrinopeptide A; Glycated Hemoglobin; Hemostasis; Humans; Imidazoles; Platelet Aggregation; Platelet Factor 4; Thromboxane-A Synthase | 1986 |
Specific thromboxane synthetase inhibition and retinopathy in insulin-dependent diabetics.
Topics: Adult; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Double-Blind Method; Female; Fluorescein Angiography; Humans; Imidazoles; Male; Middle Aged; Thromboxane-A Synthase | 1986 |